Your browser doesn't support javascript.
loading
Genetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants.
Einson, Jonah; Glinos, Dafni; Boerwinkle, Eric; Castaldi, Peter; Darbar, Dawood; de Andrade, Mariza; Ellinor, Patrick; Fornage, Myriam; Gabriel, Stacey; Germer, Soren; Gibbs, Richard; Hersh, Craig P; Johnsen, Jill; Kaplan, Robert; Konkle, Barbara A; Kooperberg, Charles; Nassir, Rami; Loos, Ruth J F; Meyers, Deborah A; Mitchell, Braxton D; Psaty, Bruce; Vasan, Ramachandran S; Rich, Stephen S; Rienstra, Michael; Rotter, Jerome I; Saferali, Aabida; Shoemaker, Moore Benjamin; Silverman, Edwin; Smith, Albert Vernon; Mohammadi, Pejman; Castel, Stephane E; Iossifov, Ivan; Lappalainen, Tuuli.
Afiliación
  • Einson J; Department of Biomedical Informatics, Columbia University, New York, NY 10027, USA.
  • Glinos D; New York Genome Center, New York, NY 10013, USA.
  • Boerwinkle E; New York Genome Center, New York, NY 10013, USA.
  • Castaldi P; School of Public Health, University of Texas Health at Houston, Houston, TX 77030, USA.
  • Darbar D; Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA.
  • de Andrade M; Department of Cardiology, University of Illinois at Chicago, Chicago, IL 60607, USA.
  • Ellinor P; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
  • Fornage M; Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Gabriel S; Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health at Houston, Houston, TX 77030, USA.
  • Germer S; Broad Institute, Cambridge, MA 02142, USA.
  • Gibbs R; New York Genome Center, New York, NY 10013, USA.
  • Hersh CP; Department of Molecular and Human Genetics, Baylor College of Medicine Human Genome Sequencing Center, Houston, TX 77030, USA.
  • Johnsen J; Channing Division of Network Medicine and Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Kaplan R; Department of Hematology, University of Washington, Seattle, WA 98195, USA.
  • Konkle BA; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Kooperberg C; Department of Hematology, University of Washington, Seattle, WA 98195, USA.
  • Nassir R; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Loos RJF; Department of Pathology, School of Medicine, Umm Al-Qura University, Mecca 24382, Saudi Arabia.
  • Meyers DA; Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Mitchell BD; Department of Medicine, University of Arizona, Tucson, AZ 85721, USA.
  • Psaty B; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Vasan RS; Geriatrics Research and Education Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, MD 21201, USA.
  • Rich SS; Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Systems and Population Health, University of Washington, Seattle, WA 98195, USA.
  • Rienstra M; Department of Medicine, Boston University, Boston, MA 02118, USA.
  • Rotter JI; Public Health Sciences, University of Virginia, Charlottesville, VA 22903, USA.
  • Saferali A; Clinical Cardiology, UMCG Cardiology, Groningen 09713, the Netherlands.
  • Shoemaker MB; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
  • Silverman E; Channing Division of Network Medicine and Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Smith AV; Department of Medicine, Vanderbilt University, Nashville, TN 37235, USA.
  • Mohammadi P; Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
  • Iossifov I; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Lappalainen T; New York Genome Center, New York, NY 10013, USA.
Genetics ; 224(4)2023 08 09.
Article en En | MEDLINE | ID: mdl-37348055
ABSTRACT
Exonic variants present some of the strongest links between genotype and phenotype. However, these variants can have significant inter-individual pathogenicity differences, known as variable penetrance. In this study, we propose a model where genetically controlled mRNA splicing modulates the pathogenicity of exonic variants. By first cataloging exonic inclusion from RNA-sequencing data in GTEx V8, we find that pathogenic alleles are depleted on highly included exons. Using a large-scale phased whole genome sequencing data from the TOPMed consortium, we observe that this effect may be driven by common splice-regulatory genetic variants, and that natural selection acts on haplotype configurations that reduce the transcript inclusion of putatively pathogenic variants, especially when limiting to haploinsufficient genes. Finally, we test if this effect may be relevant for autism risk using families from the Simons Simplex Collection, but find that splicing of pathogenic alleles has a penetrance reducing effect here as well. Overall, our results indicate that common splice-regulatory variants may play a role in reducing the damaging effects of rare exonic variants.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Empalme del ARN / Sitios de Empalme de ARN Tipo de estudio: Prognostic_studies Idioma: En Revista: Genetics Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Empalme del ARN / Sitios de Empalme de ARN Tipo de estudio: Prognostic_studies Idioma: En Revista: Genetics Año: 2023 Tipo del documento: Article